Trials / Withdrawn
WithdrawnNCT00788424
Topical Application of AS101 for the Treatment of Psoriasis
Study of Topical Application of AS101 for the Treatment of Psoriasis
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- BioMAS Ltd · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
This protocol relates to a phase II randomized double blind, placebo controlled study of the AS101 topical application for the treatment of mild to moderate Psoriasis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | AS101 Cream | 4% AS101 Cream or Placebo cream, twice a day for 12 weeks |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-02-01
- Completion
- 2010-02-01
- First posted
- 2008-11-11
- Last updated
- 2015-07-23
Locations
1 site across 1 country: Israel
Source: ClinicalTrials.gov record NCT00788424. Inclusion in this directory is not an endorsement.